Renaissance Technologies VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Renaissance Technologies ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$32,557
-17.9%
3,295,233
-9.4%
0.05%
-2.1%
Q2 2022$39,637
+9.2%
3,636,433
+13.3%
0.05%
+9.3%
Q1 2022$36,289
-28.0%
3,208,614
-0.1%
0.04%
-31.7%
Q4 2021$50,400
-10.4%
3,212,214
-2.1%
0.06%
-13.7%
Q3 2021$56,259
-21.0%
3,282,322
-0.9%
0.07%
-18.0%
Q2 2021$71,218
+28.6%
3,310,922
-10.2%
0.09%
+29.0%
Q1 2021$55,371
+5.6%
3,686,480
-7.6%
0.07%
+21.1%
Q4 2020$52,434
+23.9%
3,990,403
-8.9%
0.06%
+35.7%
Q3 2020$42,320
-12.5%
4,380,922
+3.6%
0.04%0.0%
Q2 2020$48,389
+21.3%
4,229,822
+9.9%
0.04%
+7.7%
Q1 2020$39,882
-29.6%
3,849,654
+11.5%
0.04%
-11.4%
Q4 2019$56,666
+33.0%
3,453,112
+7.6%
0.04%
+22.2%
Q3 2019$42,607
+8.1%
3,208,340
+14.7%
0.04%
+2.9%
Q2 2019$39,425
-16.5%
2,798,050
+9.1%
0.04%
-18.6%
Q1 2019$47,191
-28.1%
2,564,750
+2.1%
0.04%
-40.3%
Q4 2018$65,622
+39.6%
2,511,350
+22.6%
0.07%
+50.0%
Q3 2018$47,017
-21.2%
2,048,650
-38.3%
0.05%
+45.5%
Q2 2018$59,663
+115.9%
3,321,300
+102.5%
0.03%
+10.0%
Q1 2018$27,635
+26.7%
1,640,050
+14.3%
0.03%
+25.0%
Q4 2017$21,810
+0.0%
1,434,850
+17.8%
0.02%
-7.7%
Q3 2017$21,807
+21.8%
1,218,250
+11.0%
0.03%
+13.0%
Q2 2017$17,897
+36.1%
1,097,950
+16.9%
0.02%
+27.8%
Q1 2017$13,150
+45.1%
939,250
+65.3%
0.02%
+28.6%
Q4 2016$9,065
+26.1%
568,350
+31.5%
0.01%
+7.7%
Q3 2016$7,189
+325.4%
432,050
+186.0%
0.01%
+333.3%
Q2 2016$1,690
-51.5%
151,050
-63.8%
0.00%
-57.1%
Q1 2016$3,485
+11.0%
416,900
+23.6%
0.01%0.0%
Q4 2015$3,141
+73.2%
337,390
+72.9%
0.01%
+75.0%
Q1 2015$1,814
-35.4%
195,100
-24.0%
0.00%
-42.9%
Q3 2013$2,810
-1.8%
256,600
-27.5%
0.01%
-12.5%
Q2 2013$2,861354,1290.01%